Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM - Hallo friendsTOP POLENNEWS, In the article you read this time with the title Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cultur, Article economic, Article health, Article news, Article politique, Article sport, We write this you can understand. Alright, good read.

Title : Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM
link : Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM

Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM

As reported several years ago, median survival in this trial of high dose valproic acid (Depakote) in combination with chemoradiation was 29.6 months.  This study describes 6 patients who survived over three years (median survival over 6 years for these 6 patients).  Only 1 out of 4 evaluated tumors carried the IDH1 mutation.

https://academic.oup.com/nop/advance-article/doi/10.1093/nop/npy009/4971616  (abstract only)


http://sci-hub.tw/https://academic.oup.com/nop/advance-article/doi/10.1093/nop/npy009/4971616

Note the above link takes you to a PDF download at sci-hub.  If this link fails to work in the future, check wikipedia for the current active locations of sci-hub, and swap out the ".tw" in the URL with something else.  This is technically pirating, but most of us here would agree that fighting a brain tumor calls for such measures.

Thus Article Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM

That's an article Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Update on phase 2 trial of valproic acid + standard chemoradiation for nd GBM with the link address https://polennews.blogspot.com/2018/05/update-on-phase-2-trial-of-valproic.html

Tweet

Subscribe to receive free email updates: